Mogrify snags $16 mln
UK-based Mogrify, a provider of internal cell therapy programs, has secured $16 million in funding. Ahren Innovation Capital led the round.
14 October 2019•1 min read
UK-based Mogrify, a provider of internal cell therapy programs, has secured $16 million in funding. Ahren Innovation Capital led the round.
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
4 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
4 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
4 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
6 hours ago · 3 mins read
LDC backs London management consultancy Moorhouse after sale by Expleo
7 hours ago · 2 mins read
PAI and ICG receive VKR Holding offer for window shutter maker StellaGroup
9 hours ago · 2 mins read
